• Explore /
  • Poster
  • / A phase Ib/II study of GFH018 in combination with toripalimab in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC).

A phase Ib/II study of GFH018 in combination with toripalimab in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC).

Abstract Poster

Authors

null

Hai-Qiang Mai

Sun Yat-sen University Cancer Center (China), Guangzhou, No, China

Hai-Qiang Mai , Ye Guo , Muh-Hwa Yang , Kunyu Yang , Li-Tzong Chen , Hui Mun , Yan Yang , Shuang Wang , Huaqiang Zhu , Haige Shen , Yu Wang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT04914286

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 6026)

DOI

10.1200/JCO.2023.41.16_suppl.6026

Abstract #

6026

Poster Bd #

18

Abstract Disclosures

Similar Posters

First Author: Qin Xu

First Author: Luana Calabrò

First Author: Panpan Zhang

First Author: Ying Cheng